Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaisa Auvinen

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Lakartidningen|March 15, 2021
[Awareness of risk for transfusion reactions important for appropriate treatment]Norbert Lubenow, Marja-Kaisa Auvinen
Immunology|May 17, 2014
Expression and function of endothelial selectins during human developmentKaisa Auvinen, Sirpa Jalkanen, Marko Salmi
Transfusion|November 17, 2009
The aging population poses a global challenge for blood servicesAkif Ali, Marja-Kaisa Auvinen, Jukka Rautonen
Transfusion Medicine (Oxford, England)|November 6, 2024
Validation of pathogen reduced plasmas from maxi-pools combined with fast thawingMarja-Kaisa Auvinen, Folke Knutson, Helena Löf
Journal of Cell Science|October 9, 2008
The protein tyrosine phosphatase TCPTP controls VEGFR2 signallingElina Mattila, Kaisa Auvinen, Marko Salmi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2011
Month of birth is associated with multiple sclerosis but not with HLA-DR15 in FinlandKari-Pekka Saastamoinen, Marja-Kaisa Auvinen, Pentti J Tienari
Cancer Research|October 1, 2009
Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+ myeloid cells into tumorsFumiko Marttila-Ichihara, Kaisa Auvinen, Kati Elima, et al.
Human Immunology|November 10, 2012
Analysis of the adequate size of a cord blood bank and comparison of HLA haplotype distributions between four populationsKatri Haimila, Antti Penttilä, Anne Arvola, et al.
European Journal of Immunology|April 12, 2011
Stabilin-1/CLEVER-1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophagesSenthil Palani, Mikael Maksimow, Mari Miiluniemi, et al.
Blood|May 8, 2009
The prototype endothelial marker PAL-E is a leukocyte trafficking moleculeJohannes Keuschnigg, Tiina Henttinen, Kaisa Auvinen, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Lakartidningen|March 15, 2021
[Awareness of risk for transfusion reactions important for appropriate treatment]Norbert Lubenow, Marja-Kaisa Auvinen
Immunology|May 17, 2014
Expression and function of endothelial selectins during human developmentKaisa Auvinen, Sirpa Jalkanen, Marko Salmi
Transfusion|November 17, 2009
The aging population poses a global challenge for blood servicesAkif Ali, Marja-Kaisa Auvinen, Jukka Rautonen
Transfusion Medicine (Oxford, England)|November 6, 2024
Validation of pathogen reduced plasmas from maxi-pools combined with fast thawingMarja-Kaisa Auvinen, Folke Knutson, Helena Löf
Journal of Cell Science|October 9, 2008
The protein tyrosine phosphatase TCPTP controls VEGFR2 signallingElina Mattila, Kaisa Auvinen, Marko Salmi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2011
Month of birth is associated with multiple sclerosis but not with HLA-DR15 in FinlandKari-Pekka Saastamoinen, Marja-Kaisa Auvinen, Pentti J Tienari
Cancer Research|October 1, 2009
Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+ myeloid cells into tumorsFumiko Marttila-Ichihara, Kaisa Auvinen, Kati Elima, et al.
Human Immunology|November 10, 2012
Analysis of the adequate size of a cord blood bank and comparison of HLA haplotype distributions between four populationsKatri Haimila, Antti Penttilä, Anne Arvola, et al.
European Journal of Immunology|April 12, 2011
Stabilin-1/CLEVER-1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophagesSenthil Palani, Mikael Maksimow, Mari Miiluniemi, et al.
Blood|May 8, 2009
The prototype endothelial marker PAL-E is a leukocyte trafficking moleculeJohannes Keuschnigg, Tiina Henttinen, Kaisa Auvinen, et al.
Pageof 3